Tate & Lyle | TATE - Equity Capital And Reserves

Stock Price
355.20
Daily Change
3.00 0.85%
Monthly
1.14%
Yearly
-27.78%
Q2 Forecast
344.56

Tate & Lyle reported GBP1.55B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Agrana Beteiligungs EUR 1.11B 31.26M Sep/2025
Anglo-eastern Plants USD 584.75M 33.72M Jun/2025
Associated British Foods GBP 11.06B 64M Dec/2025
Austevoll Seafood NOK 16.01B 271M Dec/2025
Beiersdorf EUR 8.6B 133M Dec/2025
British American Tobacco GBP 46.03B 1.14B Dec/2025
Danone EUR 16.92B 1.56B Dec/2025
Diageo GBP 11.6B 1.58B Dec/2025
Givaudan CHF 4.54B 430M Dec/2025
Henkel EUR 20.5B 459M Dec/2025
Imperial Brands GBP 4.82B 142M Dec/2025
International Flavors Fragrances USD 14.15B 87M Dec/2025
Kerry EUR 6.49B 27M Dec/2024
L'Oréal EUR 34.95B 3.78B Dec/2025
Nestle CHF 32.81B 3.98B Dec/2025
Nomad Foods EUR 2.5B 57.5M Dec/2025
Ontex EUR 950.4M 100K Dec/2025
Pernod Ricard EUR 3.44B 12.78B Dec/2025
Premier Foods GBP 1.44B 115.1M Dec/2025
Primary Health Properties ZAR 2.55B 1.16B Dec/2025
Reckitt Benckiser GBP 6.7B 1.39B Dec/2024
Tate & Lyle GBP 1.55B 44M Dec/2025
Unilever EUR 15.53B 2.26B Dec/2025